ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $349.1 million versus the consensus estimate of $339.56 million.

For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.

Earnings